$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension 원문보기

Pulmonary circulation, v.9 no.1, 2019년, pp.2045894018788846 -   

Desole, Susanna (Division of Pneumology and Infectious Diseases”, Ernst-Moritz-Arndt University, Germany) ,  Richter, Manuel Jonas (Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Germany) ,  Heine, Alexander (Division of Pneumology and Infectious Diseases”, Ernst-Moritz-Arndt University, Germany) ,  Ewert, Ralf (Division of Pneumology and Infectious Diseases”, Ernst-Moritz-Arndt University, Germany)

Abstract AI-Helper 아이콘AI-Helper

Intravenous prostacyclin-based therapy improves survival in children with pulmonary arterial hypertension (PAH), but is typically administered via an external infusion pump, which places a considerable burden on the patient. Implanted pumps may overcome some of the limitations of external pumps. We ...

주제어

참고문헌 (24)

  1. 1 Abman SH Hansmann G Archer SL et al. Pediatric pulmonary hypertension: Guidelines from the American Heart Association and American Thoracic Society . Circulation 2015 ; 132 : 2037 – 2099 . 26534956 

  2. 2 Barst RJ Maislin G Fishman AP Vasodilator therapy for primary pulmonary hypertension in children . Circulation 1999 ; 99 : 1197 – 1208 . 10069788 

  3. 3 Nakayama T Shimada H Takatsuki S et al. Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children . Circ J 2007 ; 71 : 1785 – 1790 . 17965503 

  4. 4 Yung D Widlitz AC Rosenzweig EB et al. Outcomes in children with idiopathic pulmonary arterial hypertension . Circulation 2004 ; 110 : 660 – 665 . 15289375 

  5. 5 Lammers AE Hislop AA Flynn Y et al. Epoprostenol treatment in children with severe pulmonary hypertension . Heart 2007 ; 93 : 739 – 743 . 17065181 

  6. 6 Hansmann G Apitz C Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK . Heart 2016 ; 102 ( Suppl 2 ): ii67 – ii85 . 27053700 

  7. 7 Simonneau G Barst RJ Galie N et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial . Am J Respir Crit Care Med 2002 ; 165 : 800 – 804 . 11897647 

  8. 8 Doran AK Ivy DD Barst RJ et al. Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension . Int J Clin Pract Suppl 2008 ; 160 : 5 – 9 . 

  9. 9 Oudiz RJ Widlitz A Beckmann XJ et al. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension . Chest 2004 ; 126 : 90 – 94 . 15249447 

  10. 10 Ivy DD Claussen L Doran A Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil . Am J Cardiol 2007 ; 99 : 696 – 698 . 17317374 

  11. 11 Rosenzweig EB Kerstein D Barst RJ Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects . Circulation 1999 ; 99 : 1858 – 1865 . 10199883 

  12. 12 Bourge RC Waxman AB Gomberg-Maitland M et al. Treprostinil administered to treat pulmonary arterial hypertension using a fully implantable programmable intravascular delivery system: Results of the DelIVery for PAH Trial . Chest 2016 ; 150 : 27 – 34 . 27396777 

  13. 13 Ewert R Halank M Bruch L et al. A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapy . Am J Respir Crit Care Med 2012 ; 186 : 1196 – 1198 . 23204382 

  14. 14 Ewert R Richter MJ Steringer-Mascherbauer R et al. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension . Clin Res Cardiol 2017 ; 106 : 776 – 783 . 28429083 

  15. 15 Waxman AB McElderry HT Gomberg-Maitland M et al. Totally implantable IV treprostinil therapy in pulmonary hypertension assessment of the implantation procedure . Chest 2017 ; 152 : 1128 – 1134 . 28583617 

  16. 16 Richter MJ Ewert R Warnke C et al. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension . Clin Res Cardiol 2017 ; 106 : 174 – 182 . 27670656 

  17. 17 Barst RJ Ivy DD Gaitan G et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension . Circulation 2012 ; 125 : 324 – 334 . 22128226 

  18. 18 Burgess G Hoogkamer H Collings L et al. Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil . Eur J Clin Pharmacol 2008 ; 64 : 43 – 50 . 18040672 

  19. 19 Grünig E Ohnesorge J Benjamin N et al. Plasma drug concentrations in patients with pulmonary arterial hypertension on combination treatment . Respiration 2017 ; 94 : 26 – 37 . 28494463 

  20. 20 Tricumed Medizintechnik GmbH. Dringende Sicherheitsinformation: mögliche Mehrförderung bei der implantierbaren Infusionspumpe Lenus pro in Verbindung mit dem Medikament Remodulin bei mehrjähriger Anwendung, https://bfarm.johner-institut.de/Documents/7124-13_Kundeninfo_de.pdf (26 November 2013, accessed 10 May 2018) . 

  21. 21 Marr CR McSweeney JE Mullen MP et al. Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension . Pulm Circ 2015 ; 5 : 322 – 326 . 26064457 

  22. 22 Ivy DD Calderbank M Wagner BD et al. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension . Infect Control Hosp Epidemiol 2009 ; 30 : 823 – 829 . 19637961 

  23. 23 Malbezin S Gauss T Smith I et al. A review of 5434 percutaneous pediatric central venous catheters inserted by anesthesiologists . Paediatr Anaesth 2013 ; 23 : 974 – 979 . 23659462 

  24. 24 Janik JE Conlon SJ Janik JS Percutaneous central access in patients younger than 5 years: Size does matter . J Pediatr Surg 2004 ; 39 : 1252 – 1256 . 15300539 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로